Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Krystal Biotech (KRYS) Cost of Revenue (2023 - 2026)

Krystal Biotech (KRYS) has disclosed Cost of Revenue for 3 consecutive years, with $6.6 million as the latest value for Q4 2025.

  • Quarterly Cost of Revenue rose 33.2% to $6.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $23.0 million through Dec 2025, up 14.89% year-over-year, with the annual reading at $23.0 million for FY2025, 14.89% up from the prior year.
  • Cost of Revenue hit $6.6 million in Q4 2025 for Krystal Biotech, up from $4.3 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $7.2 million in Q2 2025 to a low of $223000.0 in Q3 2023.
  • Historically, Cost of Revenue has averaged $4.6 million across 3 years, with a median of $5.0 million in 2024.
  • Biggest five-year swings in Cost of Revenue: skyrocketed 2897.31% in 2024 and later tumbled 36.22% in 2025.
  • Year by year, Cost of Revenue stood at $2.9 million in 2023, then surged by 72.38% to $4.9 million in 2024, then surged by 33.2% to $6.6 million in 2025.
  • Business Quant data shows Cost of Revenue for KRYS at $6.6 million in Q4 2025, $4.3 million in Q3 2025, and $7.2 million in Q2 2025.